Previvor raises $3.3M for personalized cancer prevention

A company co-founded by Michelle Zimmerman — who previously built the oncology business at genomics company Sema4 (now GeneDx) — has raised $3.3 million to launch a comprehensive clinical program focused on personalizing cancer prevention and early detection. Previvor Edge, based in New York City, provides a single place for people to access a multidisciplinary team including physicians, nurse practitioners and genetic counselors. “Like so many families, mine has been deeply affected by cancer. Recently, someone very close to me had cancer caught early, and that saved her life,” says Zimmerman, who serves as CEO. “But many people don’t get that chance, and that has to change. We have the tools in place to defeat cancer’s reign.” Forty percent of Americans will be diagnosed with cancer in their lifetime.